Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care
ObjectivesDespite being proposed 4 years ago, there has been no independent validation study of the Rome IV criteria for IBS. We assessed their performance for the diagnosis of IBS in secondary care and compared them with the previous iteration, the Rome III criteria.DesignWe collected complete symp...
Saved in:
Published in | Gut Vol. 70; no. 6; pp. 1110 - 1116 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BMJ Publishing Group Ltd and British Society of Gastroenterology
01.06.2021
BMJ Publishing Group LTD |
Subjects | |
Online Access | Get full text |
ISSN | 0017-5749 1468-3288 1468-3288 |
DOI | 10.1136/gutjnl-2020-322519 |
Cover
Loading…
Abstract | ObjectivesDespite being proposed 4 years ago, there has been no independent validation study of the Rome IV criteria for IBS. We assessed their performance for the diagnosis of IBS in secondary care and compared them with the previous iteration, the Rome III criteria.DesignWe collected complete symptom data from consecutive adult patients with suspected IBS referred to a single UK clinic. All subjects underwent relatively standardised workup, with assessors blinded to symptom status. The reference standard used to confirm IBS was the presence of lower abdominal pain or discomfort in association with altered stool form or frequency, in a patient with no evidence of organic gastrointestinal disease after investigation. Sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% CIs, were calculated for each of the diagnostic criteria.ResultsThe level of agreement between the Rome IV and Rome III criteria was good (kappa=0.65). Compared with the reference standard, sensitivity and specificity of the Rome IV criteria in 572 patients (431 (75.3%) women, mean age 36.5 years) were 82.4% and 82.9%, respectively. Positive and negative LRs for the Rome IV criteria were 4.82 (95% CI 3.30 to 7.28) and 0.21 (95% CI 0.17 to 0.26), respectively. The Rome IV criteria performed best in those with IBS with constipation or mixed bowel habits. In 471 patients (350 (74.3%) women, mean age 36.7 years), compared with the reference standard, the sensitivity and specificity of the Rome III criteria were 85.8% and 65.0%; positive and negative LRs were 2.45 (95% CI 1.90 to 3.27) and 0.22 (0.16 to 0.29), respectively. Incorporating mood and extraintestinal symptom reporting into diagnostic criteria did not improve their performance significantly.ConclusionsThe Rome IV criteria performed significantly better than the Rome III criteria in diagnosing IBS in this single centre secondary care study, although the clinical relevance of this is uncertain. |
---|---|
AbstractList | Despite being proposed 4 years ago, there has been no independent validation study of the Rome IV criteria for IBS. We assessed their performance for the diagnosis of IBS in secondary care and compared them with the previous iteration, the Rome III criteria.OBJECTIVESDespite being proposed 4 years ago, there has been no independent validation study of the Rome IV criteria for IBS. We assessed their performance for the diagnosis of IBS in secondary care and compared them with the previous iteration, the Rome III criteria.We collected complete symptom data from consecutive adult patients with suspected IBS referred to a single UK clinic. All subjects underwent relatively standardised workup, with assessors blinded to symptom status. The reference standard used to confirm IBS was the presence of lower abdominal pain or discomfort in association with altered stool form or frequency, in a patient with no evidence of organic gastrointestinal disease after investigation. Sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% CIs, were calculated for each of the diagnostic criteria.DESIGNWe collected complete symptom data from consecutive adult patients with suspected IBS referred to a single UK clinic. All subjects underwent relatively standardised workup, with assessors blinded to symptom status. The reference standard used to confirm IBS was the presence of lower abdominal pain or discomfort in association with altered stool form or frequency, in a patient with no evidence of organic gastrointestinal disease after investigation. Sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% CIs, were calculated for each of the diagnostic criteria.The level of agreement between the Rome IV and Rome III criteria was good (kappa=0.65). Compared with the reference standard, sensitivity and specificity of the Rome IV criteria in 572 patients (431 (75.3%) women, mean age 36.5 years) were 82.4% and 82.9%, respectively. Positive and negative LRs for the Rome IV criteria were 4.82 (95% CI 3.30 to 7.28) and 0.21 (95% CI 0.17 to 0.26), respectively. The Rome IV criteria performed best in those with IBS with constipation or mixed bowel habits. In 471 patients (350 (74.3%) women, mean age 36.7 years), compared with the reference standard, the sensitivity and specificity of the Rome III criteria were 85.8% and 65.0%; positive and negative LRs were 2.45 (95% CI 1.90 to 3.27) and 0.22 (0.16 to 0.29), respectively. Incorporating mood and extraintestinal symptom reporting into diagnostic criteria did not improve their performance significantly.RESULTSThe level of agreement between the Rome IV and Rome III criteria was good (kappa=0.65). Compared with the reference standard, sensitivity and specificity of the Rome IV criteria in 572 patients (431 (75.3%) women, mean age 36.5 years) were 82.4% and 82.9%, respectively. Positive and negative LRs for the Rome IV criteria were 4.82 (95% CI 3.30 to 7.28) and 0.21 (95% CI 0.17 to 0.26), respectively. The Rome IV criteria performed best in those with IBS with constipation or mixed bowel habits. In 471 patients (350 (74.3%) women, mean age 36.7 years), compared with the reference standard, the sensitivity and specificity of the Rome III criteria were 85.8% and 65.0%; positive and negative LRs were 2.45 (95% CI 1.90 to 3.27) and 0.22 (0.16 to 0.29), respectively. Incorporating mood and extraintestinal symptom reporting into diagnostic criteria did not improve their performance significantly.The Rome IV criteria performed significantly better than the Rome III criteria in diagnosing IBS in this single centre secondary care study, although the clinical relevance of this is uncertain.CONCLUSIONSThe Rome IV criteria performed significantly better than the Rome III criteria in diagnosing IBS in this single centre secondary care study, although the clinical relevance of this is uncertain. Despite being proposed 4 years ago, there has been no independent validation study of the Rome IV criteria for IBS. We assessed their performance for the diagnosis of IBS in secondary care and compared them with the previous iteration, the Rome III criteria. We collected complete symptom data from consecutive adult patients with suspected IBS referred to a single UK clinic. All subjects underwent relatively standardised workup, with assessors blinded to symptom status. The reference standard used to confirm IBS was the presence of lower abdominal pain or discomfort in association with altered stool form or frequency, in a patient with no evidence of organic gastrointestinal disease after investigation. Sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% CIs, were calculated for each of the diagnostic criteria. The level of agreement between the Rome IV and Rome III criteria was good (kappa=0.65). Compared with the reference standard, sensitivity and specificity of the Rome IV criteria in 572 patients (431 (75.3%) women, mean age 36.5 years) were 82.4% and 82.9%, respectively. Positive and negative LRs for the Rome IV criteria were 4.82 (95% CI 3.30 to 7.28) and 0.21 (95% CI 0.17 to 0.26), respectively. The Rome IV criteria performed best in those with IBS with constipation or mixed bowel habits. In 471 patients (350 (74.3%) women, mean age 36.7 years), compared with the reference standard, the sensitivity and specificity of the Rome III criteria were 85.8% and 65.0%; positive and negative LRs were 2.45 (95% CI 1.90 to 3.27) and 0.22 (0.16 to 0.29), respectively. Incorporating mood and extraintestinal symptom reporting into diagnostic criteria did not improve their performance significantly. The Rome IV criteria performed significantly better than the Rome III criteria in diagnosing IBS in this single centre secondary care study, although the clinical relevance of this is uncertain. ObjectivesDespite being proposed 4 years ago, there has been no independent validation study of the Rome IV criteria for IBS. We assessed their performance for the diagnosis of IBS in secondary care and compared them with the previous iteration, the Rome III criteria.DesignWe collected complete symptom data from consecutive adult patients with suspected IBS referred to a single UK clinic. All subjects underwent relatively standardised workup, with assessors blinded to symptom status. The reference standard used to confirm IBS was the presence of lower abdominal pain or discomfort in association with altered stool form or frequency, in a patient with no evidence of organic gastrointestinal disease after investigation. Sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% CIs, were calculated for each of the diagnostic criteria.ResultsThe level of agreement between the Rome IV and Rome III criteria was good (kappa=0.65). Compared with the reference standard, sensitivity and specificity of the Rome IV criteria in 572 patients (431 (75.3%) women, mean age 36.5 years) were 82.4% and 82.9%, respectively. Positive and negative LRs for the Rome IV criteria were 4.82 (95% CI 3.30 to 7.28) and 0.21 (95% CI 0.17 to 0.26), respectively. The Rome IV criteria performed best in those with IBS with constipation or mixed bowel habits. In 471 patients (350 (74.3%) women, mean age 36.7 years), compared with the reference standard, the sensitivity and specificity of the Rome III criteria were 85.8% and 65.0%; positive and negative LRs were 2.45 (95% CI 1.90 to 3.27) and 0.22 (0.16 to 0.29), respectively. Incorporating mood and extraintestinal symptom reporting into diagnostic criteria did not improve their performance significantly.ConclusionsThe Rome IV criteria performed significantly better than the Rome III criteria in diagnosing IBS in this single centre secondary care study, although the clinical relevance of this is uncertain. |
Author | Black, Christopher J Ford, Alexander C Craig, Orla Gracie, David J |
Author_xml | – sequence: 1 givenname: Christopher J orcidid: 0000-0001-5449-3603 surname: Black fullname: Black, Christopher J organization: Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK – sequence: 2 givenname: Orla surname: Craig fullname: Craig, Orla organization: Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK – sequence: 3 givenname: David J orcidid: 0000-0001-9616-981X surname: Gracie fullname: Gracie, David J organization: Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK – sequence: 4 givenname: Alexander C orcidid: 0000-0001-6371-4359 surname: Ford fullname: Ford, Alexander C email: alexf12399@yahoo.com organization: Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32973070$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU1rFTEYhYNU7O3VP-BCAm7cTM3nTGYpl6oXCoKo25DPNpeZ5JrMULrwv5txWitdFFfh5TznJec9Z-AkpugAeI3ROca0fX81T4c4NAQR1FBCOO6fgQ1mraiTECdggxDuGt6x_hSclXJACAnR4xfglJK-o6hDG_Brl8ajyqGkCJOH07WDX9Po4P4HNDlMLgcFb8J0_Y-y3z9IPuU_ig3qKqYSyrIk5CorPTio040bYLmNNi_WEGFxJkWr8i00KruX4LlXQ3Gv7t4t-P7x4tvuc3P55dN-9-Gy0QyJqcFCeMyVFsKqmsByTntvaW-sUt4gznyPMfGa8J4YQrRmnWVeEeEto7hG3YJ3695jTj9nVyY5hmLcMKjo0lwkYaxtW0ERrujbR-ghzTnW30nCCUWUL-AWvLmjZj06K485jDWUvD9sBcQKmJxKyc5LU28yhRSnrMIgMZJLh3LtUC4dyrXDaiWPrPfbnzQ1q0mPh__jzx_4vwmfMPwGdUK92g |
CitedBy_id | crossref_primary_10_51847_VDfCLB5GFG crossref_primary_10_1186_s12876_023_02760_0 crossref_primary_10_1055_a_1290_8982 crossref_primary_10_47892_rgp_2024_442_1668 crossref_primary_10_1111_apt_16437 crossref_primary_10_3389_fmed_2022_914356 crossref_primary_10_1016_j_cgh_2021_08_025 crossref_primary_10_1111_apt_16351 crossref_primary_10_1016_j_cgh_2024_02_012 crossref_primary_10_1111_apt_17567 crossref_primary_10_1111_apt_16597 crossref_primary_10_1080_17474124_2025_2455586 crossref_primary_10_1111_apt_17160 crossref_primary_10_5217_ir_2023_00199 crossref_primary_10_1053_j_gastro_2021_07_034 crossref_primary_10_1053_j_gastro_2021_11_019 crossref_primary_10_1080_17474124_2023_2223975 crossref_primary_10_1111_nmo_14282 crossref_primary_10_1111_nmo_14481 crossref_primary_10_1111_nmo_14483 crossref_primary_10_1007_s40265_023_01871_y crossref_primary_10_1111_apt_16624 crossref_primary_10_1002_14651858_CD014029 crossref_primary_10_18203_2394_6040_ijcmph20250042 crossref_primary_10_12968_gasn_2024_0015 crossref_primary_10_1111_apt_18400 crossref_primary_10_1111_apt_16582 crossref_primary_10_1136_gutjnl_2021_324598 crossref_primary_10_1177_15598276221112309 crossref_primary_10_1016_j_cgh_2023_05_022 crossref_primary_10_1053_j_gastro_2023_11_307 crossref_primary_10_1111_apt_18363 crossref_primary_10_1371_journal_pone_0297836 crossref_primary_10_1111_apt_16939 crossref_primary_10_5056_jnm24018 crossref_primary_10_1111_nmo_14256 crossref_primary_10_1111_nmo_14532 crossref_primary_10_51847_19XY8dGjWy crossref_primary_10_1111_apt_16816 crossref_primary_10_51821_87_2_12586 crossref_primary_10_1111_nmo_14536 crossref_primary_10_1053_j_gastro_2022_01_021 crossref_primary_10_1016_j_gtc_2022_06_010 crossref_primary_10_1016_S2468_1253_24_00428_X crossref_primary_10_1016_j_cgh_2021_04_043 crossref_primary_10_1111_apt_16966 crossref_primary_10_1111_nmo_14388 crossref_primary_10_1016_j_cgh_2023_02_016 crossref_primary_10_3389_fpubh_2022_947097 crossref_primary_10_1111_apt_17132 crossref_primary_10_1007_s12664_024_01624_z crossref_primary_10_1111_apt_16643 crossref_primary_10_3390_microorganisms12102036 crossref_primary_10_7759_cureus_45357 crossref_primary_10_5009_gnl230396 crossref_primary_10_51821_85_2_10100 crossref_primary_10_1016_j_phymed_2022_154419 crossref_primary_10_1097_MEG_0000000000002475 |
Cites_doi | 10.1016/0016-5085(90)90822-I 10.1053/j.gastro.2013.08.048 10.1038/ajg.2016.308 10.1016/j.gie.2005.08.016 10.1111/nmo.13189 10.1053/j.gastro.2016.03.035 10.1097/00006842-200203000-00008 10.1089/thy.2006.0235 10.1111/apt.13949 10.1053/j.gastro.2016.02.014 10.1111/j.1365-2036.2010.04402.x 10.1038/s41395-018-0084-x 10.1023/B:DDAS.0000026300.47363.3b 10.1038/ajg.2016.466 10.1053/j.gastro.2019.12.021 10.1038/ajg.2014.215 10.1111/apt.13283 10.1097/01.psy.0000075977.90337.e7 10.1046/j.1365-2036.1997.142318000.x 10.1016/j.cgh.2019.05.037 10.1136/gut.39.4.580 10.1016/j.cgh.2012.11.033 10.1016/S0140-6736(01)06581-3 10.1111/apt.13074 10.7326/0003-4819-122-2-199501150-00005 10.1177/1756284818783600 10.1136/gutjnl-2017-315909 10.1016/j.cgh.2009.09.032 10.1053/gast.2002.34755 10.1111/jgh.13791 10.1038/ajg.2014.401 10.1111/j.1365-2036.2009.04081.x 10.1053/j.gastro.2005.11.061 10.1136/bmj.h701 10.1016/j.cgh.2015.03.002 10.1136/gut.42.4.551 10.1136/bmj.h5527 10.1111/apt.13227 10.1136/gut.2007.119446 10.1038/ajg.2012.260 10.1001/jama.300.15.1793 10.1053/j.gastro.2020.04.014 10.1016/j.cgh.2015.09.031 10.1111/j.1600-0447.1983.tb09716.x 10.1111/apt.15325 10.1038/ajg.2014.182 10.7861/clinmedicine.15-3-252 10.1097/01.PSY.0000075977.90337.E7 10.1053/j.gastro.2016.02.031 10.1016/S0016-5085(08)83155-1 10.1136/bmj.2.6138.653 |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88I 8AF 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1136/gutjnl-2020-322519 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Database Suite (ProQuest) Natural Science Collection BMJ Journals ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database (ProQuest) Biological Science Database (ProQuest) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Central Student |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-3288 |
EndPage | 1116 |
ExternalDocumentID | 32973070 10_1136_gutjnl_2020_322519 gutjnl |
Genre | Validation Study Journal Article Comparative Study |
GeographicLocations | United Kingdom--UK |
GeographicLocations_xml | – name: United Kingdom--UK |
GroupedDBID | --- .55 .GJ .VT 08G 0R~ 18M 29I 2WC 354 39C 3O- 4.4 40O 53G 5GY 5VS 7X7 7~S 88E 88I 8AF 8F7 8FE 8FH 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAUVZ AAWJN AAYEP ABAAH ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADFRT ADUGQ ADZCM AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AI. AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DU5 DWQXO E3Z EBS EJD F5P FD8 FEDTE FYUFA GNUQQ GX1 H13 HAJ HCIFZ HMCUK HVGLF HYE HZ~ IAO IEA IH2 IHR INH INR IOF ITC J5H KQ8 L7B LK8 M1P M2P M7P N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UKHRP UYXKK V24 VH1 VM9 VVN W8F WH7 WOQ X7M YFH YOC YQY ZGI ZXP ZY1 AAYXX ACQHZ ADGHP AERUA CITATION PHGZM CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-b408t-188f15ab88da889d5539fd39cdaafc054f9112fb2592c22bb47d4fa28fd431973 |
IEDL.DBID | 7X7 |
ISSN | 0017-5749 1468-3288 |
IngestDate | Fri Jul 11 00:10:28 EDT 2025 Fri Jul 25 11:55:36 EDT 2025 Tue Apr 01 03:09:32 EDT 2025 Thu Apr 24 23:03:07 EDT 2025 Tue Jul 01 02:49:10 EDT 2025 Thu Apr 24 22:50:41 EDT 2025 Thu Apr 24 22:50:21 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | diarrhoea irritable bowel syndrome abdominal pain |
Language | English |
License | Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b408t-188f15ab88da889d5539fd39cdaafc054f9112fb2592c22bb47d4fa28fd431973 |
Notes | Original research ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0001-5449-3603 0000-0001-6371-4359 0000-0001-9616-981X |
PMID | 32973070 |
PQID | 2523035668 |
PQPubID | 2041069 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2446668301 proquest_journals_2523035668 pubmed_primary_32973070 crossref_citationtrail_10_1136_gutjnl_2020_322519 crossref_primary_10_1136_gutjnl_2020_322519 bmj_primary_10_1136_gutjnl_2020_322519 bmj_journals_10_1136_gutjnl_2020_322519 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20210600 2021-06-00 20210601 |
PublicationDateYYYYMMDD | 2021-06-01 |
PublicationDate_xml | – month: 6 year: 2021 text: 20210600 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Gut |
PublicationTitleAbbrev | Gut |
PublicationTitleAlternate | Gut |
PublicationYear | 2021 |
Publisher | BMJ Publishing Group Ltd and British Society of Gastroenterology BMJ Publishing Group LTD |
Publisher_xml | – name: BMJ Publishing Group Ltd and British Society of Gastroenterology – name: BMJ Publishing Group LTD |
References | Sood, Gracie, Law (R46) 2015; 42 Zigmond, Snaith (R26) 1983; 67 Whitehead, Crowell, Bosmajian (R12) 1990; 98 Owens, Nelson, Talley (R45) 1995; 122 Wedlake, A'Hern, Russell (R29) 2009; 30 Spiegel, Gralnek, Bolus (R18) 2005; 62 Sanders, Carter, Hurlstone (R31) 2001; 358 Irvine, Chey, Ford (R4) 2017; 112 Banerjee, Choung, Gupta (R34) 2005; 24 Henningsen, Zimmermann, Sattel (R52) 2003; 65 Sainsbury, Sanders, Ford (R5) 2013; 11 Halpin, Ford (R6) 2012; 107 Zamani, Alizadeh-Tabari, Zamani (R51) 2019; 50 Vork, Weerts, Mujagic (R22) 2018; 30 Sperber, Bangdiwala, Drossman (R3) 2020 Kane, Irvine, Derwa (R8) 2018; 11 Drossman, Hasler (R1) 2016; 150 Orekoya, McLaughlin, Leitao (R50) 2015; 15 Sood, Camilleri, Gracie (R17) 2016; 111 Spiller, Humes, Campbell (R27) 2010; 32 Hookway, Buckner, Crosland (R43) 2015; 350 Kane, Bryan, Ford (R48) 2015; 110 Palsson, Whitehead, Törnblom (R21) 2020; 158 Lankisch, Schmidt, König (R40) 1998; 42 Slattery, Niaz, Aziz (R10) 2015; 42 Patel, Bercik, Morgan (R53) 2015; 41 Ford, Talley, Veldhuyzen van Zanten (R14) 2008; 300 Kroenke, Spitzer, Williams (R28) 2002; 64 Tibble, Sigthorsson, Foster (R15) 2002; 123 Sood, Gracie, Gold (R55) 2017; 45 Longstreth, Thompson, Chey (R23) 2006; 130 Aziz, Mumtaz, Bholah (R47) 2015; 13 Mearin, Lacy, Chang (R2) 2016; 150 Ameen, Patterson, Colopy (R33) 2001; 120 Camilleri, Busciglio, Acosta (R49) 2014; 109 Arasaradnam, Brown, Forbes (R38) 2018; 67 Löser, Möllgaard, Fölsch (R39) 1996; 39 Aoki, Belin, Clickner (R35) 2007; 17 Manning, Thompson, Heaton (R11) 1978; 277 Macaigne, Lahmek, Locher (R9) 2014; 109 Adeniji, Barnett, Di Palma (R44) 2004; 49 Tolliver, Herrera, DiPalma (R32) 1994; 89 Black, Yiannakou, Houghton (R20) 2020; 18 Kamp, Kane, Ford (R7) 2016; 14 Spiller, Aziz, Creed (R42) 2007; 56 Palsson, Whitehead, van Tilburg (R19) 2016; 150 Francis, Morris, Whorwell (R25) 1997; 11 Ford, Bercik, Morgan (R16) 2013; 145 Talley, Holtmann, Nguyen (R37) 2017; 32 Drossman, Thompson, Talley (R13) 1990; 3 Leeds, Hopper, Sidhu (R36) 2010; 8 Ford, Moayyedi, Chey (R41) 2018; 113 Bossuyt, Reitsma, Bruns (R30) 2015; 351 Palsson, Whitehead, Törnblom 2020; 158 Adeniji, Barnett, Di Palma 2004; 49 Tolliver, Herrera, DiPalma 1994; 89 Spiegel, Gralnek, Bolus 2005; 62 Manning, Thompson, Heaton 1978; 277 Bossuyt, Reitsma, Bruns 2015; 351 Irvine, Chey, Ford 2017; 112 Camilleri, Busciglio, Acosta 2014; 109 Talley, Holtmann, Nguyen 2017; 32 Wedlake, A'Hern, Russell 2009; 30 Banerjee, Choung, Gupta 2005; 24 Hookway, Buckner, Crosland 2015; 350 Mearin, Lacy, Chang 2016; 150 Longstreth, Thompson, Chey 2006; 130 Aziz, Mumtaz, Bholah 2015; 13 Vork, Weerts, Mujagic 2018; 30 Sood, Gracie, Gold 2017; 45 Ford, Bercik, Morgan 2013; 145 Kroenke, Spitzer, Williams 2002; 64 Spiller, Aziz, Creed 2007; 56 Orekoya, McLaughlin, Leitao 2015; 15 Kane, Irvine, Derwa 2018; 11 Black, Yiannakou, Houghton 2020; 18 Henningsen, Zimmermann, Sattel 2003; 65 Tibble, Sigthorsson, Foster 2002; 123 Leeds, Hopper, Sidhu 2010; 8 Sanders, Carter, Hurlstone 2001; 358 Whitehead, Crowell, Bosmajian 1990; 98 Sood, Gracie, Law 2015; 42 Zamani, Alizadeh-Tabari, Zamani 2019; 50 Sperber, Bangdiwala, Drossman 2020 Francis, Morris, Whorwell 1997; 11 Kane, Bryan, Ford 2015; 110 Arasaradnam, Brown, Forbes 2018; 67 Halpin, Ford 2012; 107 Kamp, Kane, Ford 2016; 14 Drossman, Thompson, Talley 1990; 3 Macaigne, Lahmek, Locher 2014; 109 Palsson, Whitehead, van Tilburg 2016; 150 Sainsbury, Sanders, Ford 2013; 11 Slattery, Niaz, Aziz 2015; 42 Zigmond, Snaith 1983; 67 Ford, Talley, Veldhuyzen van Zanten 2008; 300 Ford, Moayyedi, Chey 2018; 113 Löser, Möllgaard, Fölsch 1996; 39 Aoki, Belin, Clickner 2007; 17 Sood, Camilleri, Gracie 2016; 111 Spiller, Humes, Campbell 2010; 32 Drossman, Hasler 2016; 150 Patel, Bercik, Morgan 2015; 41 Ameen, Patterson, Colopy 2001; 120 Lankisch, Schmidt, König 1998; 42 Owens, Nelson, Talley 1995; 122 Francis (2024111102051606000_70.6.1110.25) 1997; 11 Sperber (2024111102051606000_70.6.1110.3) 2020 Zigmond (2024111102051606000_70.6.1110.26) 1983; 67 Halpin (2024111102051606000_70.6.1110.6) 2012; 107 2024111102051606000_70.6.1110.54 Kroenke (2024111102051606000_70.6.1110.28) 2002; 64 Henningsen (2024111102051606000_70.6.1110.52) 2003; 65 Kamp (2024111102051606000_70.6.1110.7) 2016; 14 Tibble (2024111102051606000_70.6.1110.15) 2002; 123 Wedlake (2024111102051606000_70.6.1110.29) 2009; 30 Camilleri (2024111102051606000_70.6.1110.49) 2014; 109 Tolliver (2024111102051606000_70.6.1110.32) 1994; 89 Zamani (2024111102051606000_70.6.1110.51) 2019; 50 Sood (2024111102051606000_70.6.1110.55) 2017; 45 2024111102051606000_70.6.1110.24 Spiegel (2024111102051606000_70.6.1110.18) 2005; 62 Bossuyt (2024111102051606000_70.6.1110.30) 2015; 351 Löser (2024111102051606000_70.6.1110.39) 1996; 39 Orekoya (2024111102051606000_70.6.1110.50) 2015; 15 Longstreth (2024111102051606000_70.6.1110.23) 2006; 130 Black (2024111102051606000_70.6.1110.20) 2020; 18 Aoki (2024111102051606000_70.6.1110.35) 2007; 17 Talley (2024111102051606000_70.6.1110.37) 2017; 32 Ford (2024111102051606000_70.6.1110.14) 2008; 300 Patel (2024111102051606000_70.6.1110.53) 2015; 41 Macaigne (2024111102051606000_70.6.1110.9) 2014; 109 Owens (2024111102051606000_70.6.1110.45) 1995; 122 Hookway (2024111102051606000_70.6.1110.43) 2015; 350 Lankisch (2024111102051606000_70.6.1110.40) 1998; 42 2024111102051606000_70.6.1110.33 Palsson (2024111102051606000_70.6.1110.19) 2016; 150 Slattery (2024111102051606000_70.6.1110.10) 2015; 42 Spiller (2024111102051606000_70.6.1110.42) 2007; 56 Manning (2024111102051606000_70.6.1110.11) 1978; 277 Kane (2024111102051606000_70.6.1110.8) 2018; 11 Spiller (2024111102051606000_70.6.1110.27) 2010; 32 Banerjee (2024111102051606000_70.6.1110.34) 2005; 24 Aziz (2024111102051606000_70.6.1110.47) 2015; 13 Leeds (2024111102051606000_70.6.1110.36) 2010; 8 Ford (2024111102051606000_70.6.1110.16) 2013; 145 Mearin (2024111102051606000_70.6.1110.2) 2016; 150 Vork (2024111102051606000_70.6.1110.22) 2018; 30 Sood (2024111102051606000_70.6.1110.46) 2015; 42 Sanders (2024111102051606000_70.6.1110.31) 2001; 358 Ford (2024111102051606000_70.6.1110.41) 2018; 113 Whitehead (2024111102051606000_70.6.1110.12) 1990; 98 Drossman (2024111102051606000_70.6.1110.1) 2016; 150 Drossman (2024111102051606000_70.6.1110.13) 1990; 3 Palsson (2024111102051606000_70.6.1110.21) 2020; 158 Adeniji (2024111102051606000_70.6.1110.44) 2004; 49 Sood (2024111102051606000_70.6.1110.17) 2016; 111 Sainsbury (2024111102051606000_70.6.1110.5) 2013; 11 Irvine (2024111102051606000_70.6.1110.4) 2017; 112 Kane (2024111102051606000_70.6.1110.48) 2015; 110 Arasaradnam (2024111102051606000_70.6.1110.38) 2018; 67 |
References_xml | – volume: 98 start-page: 336 year: 1990 ident: R12 article-title: Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples publication-title: Gastroenterology doi: 10.1016/0016-5085(90)90822-I – volume: 145 start-page: 1262 year: 2013 ident: R16 article-title: Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.08.048 – volume: 111 start-page: 1446 year: 2016 ident: R17 article-title: Enhancing diagnostic performance of symptom-based criteria for irritable bowel syndrome by additional history and limited diagnostic evaluation publication-title: Am J Gastroenterol doi: 10.1038/ajg.2016.308 – volume: 62 start-page: 892 year: 2005 ident: R18 article-title: Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? publication-title: Gastrointest Endosc doi: 10.1016/j.gie.2005.08.016 – volume: 30 start-page: e13189 year: 2018 ident: R22 article-title: Rome III vs Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.13189 – volume: 150 start-page: 1257 year: 2016 ident: R1 article-title: Rome IV-functional Gi disorders: disorders of gut-brain interaction publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.03.035 – volume: 64 start-page: 258 year: 2002 ident: R28 article-title: The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms publication-title: Psychosom Med doi: 10.1097/00006842-200203000-00008 – volume: 17 start-page: 1211 year: 2007 ident: R35 article-title: Serum TSH and total T4 in the United States population and their association with participant characteristics: National health and nutrition examination survey (NHANES 1999-2002) publication-title: Thyroid doi: 10.1089/thy.2006.0235 – volume: 45 start-page: 824 year: 2017 ident: R55 article-title: Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13949 – volume: 150 start-page: 1481 year: 2016 ident: R19 article-title: Development and validation of the Rome IV diagnostic questionnaire for adults publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.02.014 – volume: 32 start-page: 811 year: 2010 ident: R27 article-title: The patient health questionnaire 12 somatic symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2010.04402.x – volume: 120 year: 2001 ident: R33 article-title: Confirmation of presumptive diagnosis of irritable bowel syndrome utilizing Rome II criteria and simple laboratory screening tests with diagnostic Gi evaluation publication-title: Gastroenterology – volume: 113 start-page: 1 year: 2018 ident: R41 article-title: American College of gastroenterology monograph on management of irritable bowel syndrome publication-title: Am J Gastroenterol doi: 10.1038/s41395-018-0084-x – volume: 49 start-page: 572 year: 2004 ident: R44 article-title: Durability of the diagnosis of irritable bowel syndrome based on clinical criteria publication-title: Dig Dis Sci doi: 10.1023/B:DDAS.0000026300.47363.3b – volume: 112 start-page: 65 year: 2017 ident: R4 article-title: Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis publication-title: Am J Gastroenterol doi: 10.1038/ajg.2016.466 – volume: 158 start-page: 1262 year: 2020 ident: R21 article-title: Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.12.021 – volume: 109 start-page: 1621 year: 2014 ident: R49 article-title: Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.215 – volume: 42 start-page: 491 year: 2015 ident: R46 article-title: Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13283 – volume: 65 start-page: 528 year: 2003 ident: R52 article-title: Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review publication-title: Psychosom Med doi: 10.1097/01.psy.0000075977.90337.e7 – volume: 11 start-page: 395 year: 1997 ident: R25 article-title: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress publication-title: Aliment Pharmacol Ther doi: 10.1046/j.1365-2036.1997.142318000.x – volume: 18 start-page: 392 year: 2020 ident: R20 article-title: Epidemiological, clinical, and psychological characteristics of individuals with self-reported irritable bowel syndrome based on the Rome IV vs Rome III criteria publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2019.05.037 – volume: 39 start-page: 580 year: 1996 ident: R39 article-title: Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test publication-title: Gut doi: 10.1136/gut.39.4.580 – volume: 11 start-page: 359 year: 2013 ident: R5 article-title: Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2012.11.033 – volume: 358 start-page: 1504 year: 2001 ident: R31 article-title: Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling Rome II criteria referred to secondary care publication-title: Lancet doi: 10.1016/S0140-6736(01)06581-3 – volume: 41 start-page: 449 year: 2015 ident: R53 article-title: Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13074 – volume: 122 start-page: 107 year: 1995 ident: R45 article-title: The irritable bowel syndrome: long-term prognosis and the physician-patient interaction publication-title: Ann Intern Med doi: 10.7326/0003-4819-122-2-199501150-00005 – volume: 11 year: 2018 ident: R8 article-title: High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment publication-title: Therap Adv Gastroenterol doi: 10.1177/1756284818783600 – volume: 24 start-page: 164 year: 2005 ident: R34 article-title: Rome I criteria are more sensitive than Rome II for diagnosis of irritable bowel syndrome in Indian patients publication-title: Indian J Gastroenterol – volume: 67 start-page: 1380 year: 2018 ident: R38 article-title: Guidelines for the investigation of chronic diarrhoea in adults: British Society of gastroenterology, 3rd edition publication-title: Gut doi: 10.1136/gutjnl-2017-315909 – volume: 8 start-page: 433 year: 2010 ident: R36 article-title: Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2009.09.032 – volume: 123 start-page: 450 year: 2002 ident: R15 article-title: Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease publication-title: Gastroenterology doi: 10.1053/gast.2002.34755 – volume: 32 start-page: 1813 year: 2017 ident: R37 article-title: Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional Gi disorder patients with diarrhea or abdominal pain publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.13791 – volume: 110 start-page: 351 year: 2015 ident: R48 article-title: Reducing the need for random colonic biopsies in patients with diarrhea publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.401 – volume: 30 start-page: 707 year: 2009 ident: R29 article-title: Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2009.04081.x – volume: 277 start-page: 653 year: 1978 ident: R11 article-title: Towards positive diagnosis of the irritable bowel publication-title: BMJ – volume: 130 start-page: 1480 year: 2006 ident: R23 article-title: Functional bowel disorders publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.11.061 – volume: 350 start-page: h701 year: 2015 ident: R43 article-title: Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance publication-title: BMJ doi: 10.1136/bmj.h701 – volume: 13 start-page: 1650 year: 2015 ident: R47 article-title: High prevalence of idiopathic bile acid diarrhea among patients with diarrhea-predominant irritable bowel syndrome based on Rome III criteria publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2015.03.002 – volume: 150 start-page: 1393 year: 2016 ident: R2 article-title: Bowel disorders publication-title: Gastroenterology – volume: 89 start-page: 176 year: 1994 ident: R32 article-title: Evaluation of patients who meet clinical criteria for irritable bowel syndrome publication-title: Am J Gastroenterol – volume: 42 start-page: 551 year: 1998 ident: R40 article-title: Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency publication-title: Gut doi: 10.1136/gut.42.4.551 – volume: 351 year: 2015 ident: R30 article-title: STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies publication-title: BMJ doi: 10.1136/bmj.h5527 – volume: 42 start-page: 3 year: 2015 ident: R10 article-title: Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13227 – volume: 3 start-page: 159 year: 1990 ident: R13 article-title: Identification of sub-groups of functional gastrointestinal disorders publication-title: Gastroenterology Intl – volume: 56 start-page: 1770 year: 2007 ident: R42 article-title: Guidelines on the irritable bowel syndrome: mechanisms and practical management publication-title: Gut doi: 10.1136/gut.2007.119446 – volume: 107 start-page: 1474 year: 2012 ident: R6 article-title: Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.260 – volume: 300 start-page: 1793 year: 2008 ident: R14 article-title: Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? publication-title: JAMA doi: 10.1001/jama.300.15.1793 – year: 2020 ident: R3 article-title: Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.04.014 – volume: 14 start-page: 659 year: 2016 ident: R7 article-title: Irritable bowel syndrome and microscopic colitis: a systematic review and meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2015.09.031 – volume: 67 start-page: 361 year: 1983 ident: R26 article-title: The hospital anxiety and depression scale publication-title: Acta Psychiatr Scand doi: 10.1111/j.1600-0447.1983.tb09716.x – volume: 50 start-page: 132 year: 2019 ident: R51 article-title: Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.15325 – volume: 109 start-page: 1461 year: 2014 ident: R9 article-title: Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.182 – volume: 15 start-page: 252 year: 2015 ident: R50 article-title: Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy publication-title: Clin Med doi: 10.7861/clinmedicine.15-3-252 – volume: 3 start-page: 159 year: 1990 article-title: Identification of sub-groups of functional gastrointestinal disorders publication-title: Gastroenterology Intl – volume: 64 start-page: 258 year: 2002 article-title: The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms publication-title: Psychosom Med doi: 10.1097/00006842-200203000-00008 – volume: 350 start-page: h701 year: 2015 article-title: Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance publication-title: BMJ doi: 10.1136/bmj.h701 – volume: 49 start-page: 572 year: 2004 article-title: Durability of the diagnosis of irritable bowel syndrome based on clinical criteria publication-title: Dig Dis Sci doi: 10.1023/B:DDAS.0000026300.47363.3b – volume: 11 start-page: 359 year: 2013 article-title: Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2012.11.033 – volume: 158 start-page: 1262 year: 2020 article-title: Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.12.021 – volume: 122 start-page: 107 year: 1995 article-title: The irritable bowel syndrome: long-term prognosis and the physician-patient interaction publication-title: Ann Intern Med doi: 10.7326/0003-4819-122-2-199501150-00005 – volume: 109 start-page: 1461 year: 2014 article-title: Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.182 – volume: 358 start-page: 1504 year: 2001 article-title: Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling Rome II criteria referred to secondary care publication-title: Lancet doi: 10.1016/S0140-6736(01)06581-3 – volume: 120 year: 2001 article-title: Confirmation of presumptive diagnosis of irritable bowel syndrome utilizing Rome II criteria and simple laboratory screening tests with diagnostic Gi evaluation publication-title: Gastroenterology – volume: 123 start-page: 450 year: 2002 article-title: Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease publication-title: Gastroenterology doi: 10.1053/gast.2002.34755 – volume: 110 start-page: 351 year: 2015 article-title: Reducing the need for random colonic biopsies in patients with diarrhea publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.401 – volume: 112 start-page: 65 year: 2017 article-title: Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis publication-title: Am J Gastroenterol doi: 10.1038/ajg.2016.466 – volume: 11 year: 2018 article-title: High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment publication-title: Therap Adv Gastroenterol doi: 10.1177/1756284818783600 – volume: 113 start-page: 1 year: 2018 article-title: American College of gastroenterology monograph on management of irritable bowel syndrome publication-title: Am J Gastroenterol doi: 10.1038/s41395-018-0084-x – volume: 50 start-page: 132 year: 2019 article-title: Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.15325 – volume: 150 start-page: 1257 year: 2016 article-title: Rome IV-functional Gi disorders: disorders of gut-brain interaction publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.03.035 – volume: 39 start-page: 580 year: 1996 article-title: Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test publication-title: Gut doi: 10.1136/gut.39.4.580 – volume: 277 start-page: 653 year: 1978 article-title: Towards positive diagnosis of the irritable bowel publication-title: BMJ – volume: 145 start-page: 1262 year: 2013 article-title: Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.08.048 – volume: 351 year: 2015 article-title: STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies publication-title: BMJ doi: 10.1136/bmj.h5527 – volume: 56 start-page: 1770 year: 2007 article-title: Guidelines on the irritable bowel syndrome: mechanisms and practical management publication-title: Gut doi: 10.1136/gut.2007.119446 – volume: 15 start-page: 252 year: 2015 article-title: Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy publication-title: Clin Med doi: 10.7861/clinmedicine.15-3-252 – year: 2020 article-title: Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.04.014 – volume: 41 start-page: 449 year: 2015 article-title: Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13074 – volume: 107 start-page: 1474 year: 2012 article-title: Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.260 – volume: 45 start-page: 824 year: 2017 article-title: Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13949 – volume: 67 start-page: 1380 year: 2018 article-title: Guidelines for the investigation of chronic diarrhoea in adults: British Society of gastroenterology, 3rd edition publication-title: Gut doi: 10.1136/gutjnl-2017-315909 – volume: 150 start-page: 1393 year: 2016 article-title: Bowel disorders publication-title: Gastroenterology – volume: 13 start-page: 1650 year: 2015 article-title: High prevalence of idiopathic bile acid diarrhea among patients with diarrhea-predominant irritable bowel syndrome based on Rome III criteria publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2015.03.002 – volume: 300 start-page: 1793 year: 2008 article-title: Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? publication-title: JAMA doi: 10.1001/jama.300.15.1793 – volume: 18 start-page: 392 year: 2020 article-title: Epidemiological, clinical, and psychological characteristics of individuals with self-reported irritable bowel syndrome based on the Rome IV vs Rome III criteria publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2019.05.037 – volume: 150 start-page: 1481 year: 2016 article-title: Development and validation of the Rome IV diagnostic questionnaire for adults publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.02.014 – volume: 30 start-page: e13189 year: 2018 article-title: Rome III vs Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.13189 – volume: 42 start-page: 551 year: 1998 article-title: Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency publication-title: Gut doi: 10.1136/gut.42.4.551 – volume: 17 start-page: 1211 year: 2007 article-title: Serum TSH and total T4 in the United States population and their association with participant characteristics: National health and nutrition examination survey (NHANES 1999-2002) publication-title: Thyroid doi: 10.1089/thy.2006.0235 – volume: 24 start-page: 164 year: 2005 article-title: Rome I criteria are more sensitive than Rome II for diagnosis of irritable bowel syndrome in Indian patients publication-title: Indian J Gastroenterol – volume: 42 start-page: 3 year: 2015 article-title: Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13227 – volume: 98 start-page: 336 year: 1990 article-title: Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples publication-title: Gastroenterology doi: 10.1016/0016-5085(90)90822-I – volume: 111 start-page: 1446 year: 2016 article-title: Enhancing diagnostic performance of symptom-based criteria for irritable bowel syndrome by additional history and limited diagnostic evaluation publication-title: Am J Gastroenterol doi: 10.1038/ajg.2016.308 – volume: 89 start-page: 176 year: 1994 article-title: Evaluation of patients who meet clinical criteria for irritable bowel syndrome publication-title: Am J Gastroenterol – volume: 62 start-page: 892 year: 2005 article-title: Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? publication-title: Gastrointest Endosc doi: 10.1016/j.gie.2005.08.016 – volume: 32 start-page: 1813 year: 2017 article-title: Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional Gi disorder patients with diarrhea or abdominal pain publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.13791 – volume: 109 start-page: 1621 year: 2014 article-title: Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.215 – volume: 67 start-page: 361 year: 1983 article-title: The hospital anxiety and depression scale publication-title: Acta Psychiatr Scand doi: 10.1111/j.1600-0447.1983.tb09716.x – volume: 8 start-page: 433 year: 2010 article-title: Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2009.09.032 – volume: 130 start-page: 1480 year: 2006 article-title: Functional bowel disorders publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.11.061 – volume: 32 start-page: 811 year: 2010 article-title: The patient health questionnaire 12 somatic symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2010.04402.x – volume: 42 start-page: 491 year: 2015 article-title: Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13283 – volume: 14 start-page: 659 year: 2016 article-title: Irritable bowel syndrome and microscopic colitis: a systematic review and meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2015.09.031 – volume: 30 start-page: 707 year: 2009 article-title: Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2009.04081.x – volume: 65 start-page: 528 year: 2003 article-title: Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review publication-title: Psychosom Med doi: 10.1097/01.psy.0000075977.90337.e7 – volume: 11 start-page: 395 year: 1997 article-title: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress publication-title: Aliment Pharmacol Ther doi: 10.1046/j.1365-2036.1997.142318000.x – volume: 45 start-page: 824 year: 2017 ident: 2024111102051606000_70.6.1110.55 article-title: Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13949 – volume: 98 start-page: 336 year: 1990 ident: 2024111102051606000_70.6.1110.12 article-title: Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples publication-title: Gastroenterology doi: 10.1016/0016-5085(90)90822-I – volume: 42 start-page: 551 year: 1998 ident: 2024111102051606000_70.6.1110.40 article-title: Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency publication-title: Gut doi: 10.1136/gut.42.4.551 – volume: 130 start-page: 1480 year: 2006 ident: 2024111102051606000_70.6.1110.23 article-title: Functional bowel disorders publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.11.061 – volume: 89 start-page: 176 year: 1994 ident: 2024111102051606000_70.6.1110.32 article-title: Evaluation of patients who meet clinical criteria for irritable bowel syndrome publication-title: Am J Gastroenterol – volume: 110 start-page: 351 year: 2015 ident: 2024111102051606000_70.6.1110.48 article-title: Reducing the need for random colonic biopsies in patients with diarrhea publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.401 – volume: 64 start-page: 258 year: 2002 ident: 2024111102051606000_70.6.1110.28 article-title: The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms publication-title: Psychosom Med doi: 10.1097/00006842-200203000-00008 – volume: 150 start-page: 1481 year: 2016 ident: 2024111102051606000_70.6.1110.19 article-title: Development and validation of the Rome IV diagnostic questionnaire for adults publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.02.014 – volume: 17 start-page: 1211 year: 2007 ident: 2024111102051606000_70.6.1110.35 article-title: Serum TSH and total T4 in the United States population and their association with participant characteristics: National health and nutrition examination survey (NHANES 1999-2002) publication-title: Thyroid doi: 10.1089/thy.2006.0235 – volume: 32 start-page: 811 year: 2010 ident: 2024111102051606000_70.6.1110.27 article-title: The patient health questionnaire 12 somatic symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2010.04402.x – volume: 62 start-page: 892 year: 2005 ident: 2024111102051606000_70.6.1110.18 article-title: Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? publication-title: Gastrointest Endosc doi: 10.1016/j.gie.2005.08.016 – volume: 123 start-page: 450 year: 2002 ident: 2024111102051606000_70.6.1110.15 article-title: Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease publication-title: Gastroenterology doi: 10.1053/gast.2002.34755 – volume: 11 start-page: 395 year: 1997 ident: 2024111102051606000_70.6.1110.25 article-title: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress publication-title: Aliment Pharmacol Ther doi: 10.1046/j.1365-2036.1997.142318000.x – volume: 351 year: 2015 ident: 2024111102051606000_70.6.1110.30 article-title: STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies publication-title: BMJ doi: 10.1136/bmj.h5527 – volume: 42 start-page: 491 year: 2015 ident: 2024111102051606000_70.6.1110.46 article-title: Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13283 – volume: 65 start-page: 528 year: 2003 ident: 2024111102051606000_70.6.1110.52 article-title: Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review publication-title: Psychosom Med doi: 10.1097/01.PSY.0000075977.90337.E7 – volume: 113 start-page: 1 year: 2018 ident: 2024111102051606000_70.6.1110.41 article-title: American College of gastroenterology monograph on management of irritable bowel syndrome publication-title: Am J Gastroenterol doi: 10.1038/s41395-018-0084-x – volume: 107 start-page: 1474 year: 2012 ident: 2024111102051606000_70.6.1110.6 article-title: Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.260 – volume: 50 start-page: 132 year: 2019 ident: 2024111102051606000_70.6.1110.51 article-title: Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.15325 – volume: 67 start-page: 1380 year: 2018 ident: 2024111102051606000_70.6.1110.38 article-title: Guidelines for the investigation of chronic diarrhoea in adults: British Society of gastroenterology, 3rd edition publication-title: Gut doi: 10.1136/gutjnl-2017-315909 – volume: 14 start-page: 659 year: 2016 ident: 2024111102051606000_70.6.1110.7 article-title: Irritable bowel syndrome and microscopic colitis: a systematic review and meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2015.09.031 – volume: 150 start-page: 1393 year: 2016 ident: 2024111102051606000_70.6.1110.2 article-title: Bowel disorders publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.02.031 – volume: 42 start-page: 3 year: 2015 ident: 2024111102051606000_70.6.1110.10 article-title: Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13227 – volume: 11 start-page: 359 year: 2013 ident: 2024111102051606000_70.6.1110.5 article-title: Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2012.11.033 – volume: 49 start-page: 572 year: 2004 ident: 2024111102051606000_70.6.1110.44 article-title: Durability of the diagnosis of irritable bowel syndrome based on clinical criteria publication-title: Dig Dis Sci doi: 10.1023/B:DDAS.0000026300.47363.3b – volume: 32 start-page: 1813 year: 2017 ident: 2024111102051606000_70.6.1110.37 article-title: Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional Gi disorder patients with diarrhea or abdominal pain publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.13791 – volume: 18 start-page: 392 year: 2020 ident: 2024111102051606000_70.6.1110.20 article-title: Epidemiological, clinical, and psychological characteristics of individuals with self-reported irritable bowel syndrome based on the Rome IV vs Rome III criteria publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2019.05.037 – ident: 2024111102051606000_70.6.1110.33 doi: 10.1016/S0016-5085(08)83155-1 – volume: 30 start-page: e13189 year: 2018 ident: 2024111102051606000_70.6.1110.22 article-title: Rome III vs Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.13189 – volume: 112 start-page: 65 year: 2017 ident: 2024111102051606000_70.6.1110.4 article-title: Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis publication-title: Am J Gastroenterol doi: 10.1038/ajg.2016.466 – volume: 109 start-page: 1621 year: 2014 ident: 2024111102051606000_70.6.1110.49 article-title: Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.215 – volume: 109 start-page: 1461 year: 2014 ident: 2024111102051606000_70.6.1110.9 article-title: Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.182 – volume: 300 start-page: 1793 year: 2008 ident: 2024111102051606000_70.6.1110.14 article-title: Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? publication-title: JAMA doi: 10.1001/jama.300.15.1793 – volume: 8 start-page: 433 year: 2010 ident: 2024111102051606000_70.6.1110.36 article-title: Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2009.09.032 – volume: 350 start-page: h701 year: 2015 ident: 2024111102051606000_70.6.1110.43 article-title: Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance publication-title: BMJ doi: 10.1136/bmj.h701 – ident: 2024111102051606000_70.6.1110.54 – volume: 56 start-page: 1770 year: 2007 ident: 2024111102051606000_70.6.1110.42 article-title: Guidelines on the irritable bowel syndrome: mechanisms and practical management publication-title: Gut doi: 10.1136/gut.2007.119446 – volume: 11 year: 2018 ident: 2024111102051606000_70.6.1110.8 article-title: High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment publication-title: Therap Adv Gastroenterol doi: 10.1177/1756284818783600 – volume: 13 start-page: 1650 year: 2015 ident: 2024111102051606000_70.6.1110.47 article-title: High prevalence of idiopathic bile acid diarrhea among patients with diarrhea-predominant irritable bowel syndrome based on Rome III criteria publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2015.03.002 – volume: 277 start-page: 653 year: 1978 ident: 2024111102051606000_70.6.1110.11 article-title: Towards positive diagnosis of the irritable bowel publication-title: BMJ doi: 10.1136/bmj.2.6138.653 – volume: 3 start-page: 159 year: 1990 ident: 2024111102051606000_70.6.1110.13 article-title: Identification of sub-groups of functional gastrointestinal disorders publication-title: Gastroenterology Intl – volume: 158 start-page: 1262 year: 2020 ident: 2024111102051606000_70.6.1110.21 article-title: Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.12.021 – volume: 150 start-page: 1257 year: 2016 ident: 2024111102051606000_70.6.1110.1 article-title: Rome IV-functional Gi disorders: disorders of gut-brain interaction publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.03.035 – volume: 145 start-page: 1262 year: 2013 ident: 2024111102051606000_70.6.1110.16 article-title: Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.08.048 – volume: 39 start-page: 580 year: 1996 ident: 2024111102051606000_70.6.1110.39 article-title: Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test publication-title: Gut doi: 10.1136/gut.39.4.580 – volume: 24 start-page: 164 year: 2005 ident: 2024111102051606000_70.6.1110.34 article-title: Rome I criteria are more sensitive than Rome II for diagnosis of irritable bowel syndrome in Indian patients publication-title: Indian J Gastroenterol – volume: 41 start-page: 449 year: 2015 ident: 2024111102051606000_70.6.1110.53 article-title: Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13074 – volume: 67 start-page: 361 year: 1983 ident: 2024111102051606000_70.6.1110.26 article-title: The hospital anxiety and depression scale publication-title: Acta Psychiatr Scand doi: 10.1111/j.1600-0447.1983.tb09716.x – volume: 15 start-page: 252 year: 2015 ident: 2024111102051606000_70.6.1110.50 article-title: Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy publication-title: Clin Med doi: 10.7861/clinmedicine.15-3-252 – volume: 358 start-page: 1504 year: 2001 ident: 2024111102051606000_70.6.1110.31 article-title: Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling Rome II criteria referred to secondary care publication-title: Lancet doi: 10.1016/S0140-6736(01)06581-3 – volume: 122 start-page: 107 year: 1995 ident: 2024111102051606000_70.6.1110.45 article-title: The irritable bowel syndrome: long-term prognosis and the physician-patient interaction publication-title: Ann Intern Med doi: 10.7326/0003-4819-122-2-199501150-00005 – year: 2020 ident: 2024111102051606000_70.6.1110.3 article-title: Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study publication-title: Gastroenterology – volume: 111 start-page: 1446 year: 2016 ident: 2024111102051606000_70.6.1110.17 article-title: Enhancing diagnostic performance of symptom-based criteria for irritable bowel syndrome by additional history and limited diagnostic evaluation publication-title: Am J Gastroenterol doi: 10.1038/ajg.2016.308 – volume: 30 start-page: 707 year: 2009 ident: 2024111102051606000_70.6.1110.29 article-title: Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2009.04081.x – ident: 2024111102051606000_70.6.1110.24 |
SSID | ssj0008891 |
Score | 2.5589025 |
Snippet | ObjectivesDespite being proposed 4 years ago, there has been no independent validation study of the Rome IV criteria for IBS. We assessed their performance for... Despite being proposed 4 years ago, there has been no independent validation study of the Rome IV criteria for IBS. We assessed their performance for the... |
SourceID | proquest pubmed crossref bmj |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1110 |
SubjectTerms | Abdomen abdominal pain Abdominal Pain - etiology Acids Adult Anxiety Bile Celiac disease Clinical medicine Colonoscopy Constipation Constipation - etiology Diagnosis Diarrhea Diarrhea - etiology diarrhoea Family physicians Female Gastrointestinal diseases Humans Inflammatory bowel disease Intestine Irritable bowel syndrome Irritable Bowel Syndrome - complications Irritable Bowel Syndrome - diagnosis Likelihood Functions Male Medical referrals Middle Aged Mood Neurogastroenterology Pain Physicians Primary care Questionnaires Secondary Care Sensitivity and Specificity Symptom Assessment - methods Validation studies |
Title | Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care |
URI | https://gut.bmj.com/content/70/6/1110.full https://www.ncbi.nlm.nih.gov/pubmed/32973070 https://www.proquest.com/docview/2523035668 https://www.proquest.com/docview/2446668301 |
Volume | 70 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9tAEB4VIiEuFZRHAylaJNQekEW8ttfrU9VGREklUBUVlJu16_WioGBDHkIc-O_M-BV6aNTzPmzNzs5889gZgLOutCm3wnUSa7WD-pY7GtWkQ9aG8hFD4ELKtrgWgxv_1zgYVw63eZVWWcvEQlCbPCEf-QUn96WH4EN-f3xyqGsURVerFhob0KLSZWR8hePG4KIMHreWxEHoR_WjGU9c3C0X99kUeYQeEHN6vonKRT_c_62e_oE5C93T34GPFWhkP8pT3oUPafYJtq6qsPgevPaaboIstwwxHRvlDykb3jIUClSNWTFyuL4bGQ5XQ4hbixFTpt1N5rTJZEZuAz1Nmc6f0ymrSxuwScbmZEUbNXthlDi2Dzf9yz-9gVP1VXC035ULx5XSuoHSUhqFJDJB4EXWeFFilLIJYjiLEpBbjZYRTzjX2g-NbxWX1iDciELvADazPEs_A-OeiMKuQUFh0DLzAwTBPBGCKx5aIXTQhm9I1Li6F_O4MDk8EZfkj4n8cUn-NnylmY9ljY21E936hOKkqmNO7TSma9ecN2v-5wud-uBXf77ivzacNsN4FynAorI0X-IcCo4LiTKzDYclwzSf86hJGMrXo_WbH8M2p6yZws_Tgc3FbJl-Qdiz0CcFb59A6-fl9e_RG8TK_iI |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXBOW1UKgr8TigqBsncZwDQqi02vR1qFq0t9SObbTVNin7UNUDf4nfyExeWw6seuktkl_ReDzzzcMegPd96Sx3wvdy57SH-pZ7GtWkR9aGChFD4EDKtjgSg9NwbxgNV-BPexeG0ipbmVgJalPm5CPf4uS-DBB8yK-XvzyqGkXR1baERs0W-_b6Ck226Zf0O-7vB853d062B15TVcDTYV_OPF9K50dKS2mUlImJoiBxJkhyo5TLEcE4PP_cabQLeM651mFsQqe4dAaVbRIHOO89uI_ffUohjIedgUcZQ34r-aM4TNpLOoHY-jmfnRdj5Em6sMzpuigqM31x_q86_A_GrXTd7hN43IBU9q3mqqewYos1eHDYhOGfwe_trnohKx1DDMmOywvL0h8MhRC9_qwYOXhvtKTpoglxctVi6jS_0ZQmGU3ITaHHlunyyo5Z-5QCGxVsSla7UZNrRolqz-H0Tij-AlaLsrCvgPFAJHHfoGAyaAmGEYJungvBFY-dEDrqwSckatacw2lWmTiByGryZ0T-rCZ_Dz5Sz8v6TY-lHf12h7K8eTedyneMl4753I25zQrr7cYv_nzB7z3Y7Jrx7FNARxW2nGMfCsYLiTK6By9rhumWC6goGcrz18sn34CHg5PDg-wgPdp_A484ZexUPqZ1WJ1N5vYtQq6ZflfxOYOzuz5YfwEzTjm4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcEG8WChiJxwFFu7ETxzkghFpWDYUKIYr2FuzYRlttk7IPVT3wx_h1zOS1cGDFpWc_Eo3n8c14PAPwbKS8416GQeG9CdDe8sCgmQzI29ARYghcSNkWR_LgOHo_iSdb8Kt7C0NplZ1OrBW1rQqKkQ85hS8Fgg819G1axKf98ZuzHwF1kKKb1q6dRsMih-7iHN23xetsH8_6Oefjd1_2DoK2w0BgopFaBqFSPoy1UcpqpVIbxyL1VqSF1doXiGY86gLuDfoIvODcmCixkddceYuGN00E7nsFriYCzSbKUjLpnT3KHgo7KxAnUdo92BFy-H21PClnyJ_0eJnT01E0bOb05G_T-A-8W9u98Q243gJW9rbhsJuw5cpbsPOxvZK_DT_3-k6GrPIM8ST7XJ06ln1lqJCoErRmFOz9YyTL1kOImesR26T8TRe0yXROIQszc8xU527GurIKbFqyBXnwVs8vGCWt3YHjS6H4Xdguq9LdB8aFTJORRSVl0SuMYgTgvJCSa554KU08gJdI1LyVyUVeuztC5g35cyJ_3pB_AC9o5llT32PjxLA7obxoa6hTK4_ZxjWv-jX_84Xd7uDXf77m_QE87YdRD9Dlji5dtcI5dDEvFerrAdxrGKb_nKAGZajbH2ze_AnsoEjlH7Kjw4dwjVPyTh1u2oXt5XzlHiH6WprHNZsz-HbZcvUb9Sw97g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+the+Rome+IV+criteria+with+the+Rome+III+criteria+for+the+diagnosis+of+irritable+bowel+syndrome+in+secondary+care&rft.jtitle=Gut&rft.au=Black%2C+Christopher+J&rft.au=Craig%2C+Orla&rft.au=Gracie%2C+David+J&rft.au=Ford%2C+Alexander+C&rft.date=2021-06-01&rft.issn=0017-5749&rft.eissn=1468-3288&rft.volume=70&rft.issue=6&rft.spage=1110&rft.epage=1116&rft_id=info:doi/10.1136%2Fgutjnl-2020-322519&rft_id=info%3Apmid%2F32973070&rft.externalDBID=gut&rft.externalDocID=gutjnl |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0017-5749&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0017-5749&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0017-5749&client=summon |